Kromek Share Discussion Threads

[jimtech] 09/12/2020 19:07

That's great but it needs to be better than normal! I think it could go great guns but needs bigger wins to do so.

[sev22] 09/12/2020 18:50

Kromek Group say two contract extensions prove business is back to normality.

[jimtech] 09/12/2020 16:58

Milton have said they have sold because they see better opportunities elsewhere. Whilst recent the announcement of contract extensions are encouraging management need to deliver more significant wins before the share price makes serious gains IMHO. This is a highly speculative investment and I remain a holder because, whilst disappointing so far the reward could be significant if they do deliver. Or are taken over. Here's hoping.

[slicethepie] 09/12/2020 16:15

Miton have had chunky redemptions so reflects that and not necessarily a view on the company. That said i share your view that a t/o might be the answer, ce tells a great story and is fab at spending money but yet to be reflected in orders. The agencies they are working with can act quickly when they see a need and the right product ( see Thruvision as an example') but suspect they might not quite have the right product yet.

[davethechef] 09/12/2020 15:41

Update by proactive investors.co issued today, can't post but company suggesting business virtually back operating in full recovery mode now.
Market seems to be absorbing those 3 x 350k odd sells today; all at 12p.

[wigwammer] 09/12/2020 15:16

Jimtech - Dave is making the point that KMK is seeing recovery in its 3 main markets. The point that equity development are saying it is neither here nor there - the point is, KMK probably ARE seeing a recovery. In addition, we are hopefully weeks away from deployment of the biothreat detector. If none of this appeals then it makes little sense to hold the shares.

[jimtech] 09/12/2020 10:00

As wisecat2 says, you won't find a negative report on any company from Equity Development as the reports are paid for by its corporate clients.
The Equity Development Kromek report is written by Paul Hill (on here as Brummy_git) who has been a long term advocate of Kromek.
Paul is incredibly enthusiastic about Kromek and writes that "we think Kromek is inching closer to securing several largescale deployments of its
leading D3S technology across major conurbations. Each of which have the potential to generate £’ms in revenues."
The trouble is Kromek has been inching for too long. It has incredible technology that has enormous potential but Kromek has failed to deliver that potential to date.
Premier Milton have sold because of this failure.
I think an takeover could be the only way to make the most of these products and the technology.
I am a holder at an average of 14.75p

[wigwammer] 09/12/2020 09:18

Derek Bulmer - former finance director - oversaw a substantial contract write down that has materially affected perceptions of the group. With respect, it isn't obvious why his leaving is such a great loss for shareholders.

[wisecat2] 09/12/2020 07:21

Firstly Equity Development is paid research. Secondly the company burns more cash than my wife ( maybe )Thats a lot of investment over the years for little return. It feels
like that customers lease great products cheaply. We wake every day hoping for that large game changing order but nothing of real note so far. Lets hope 2021 brings some joy. Derek Bulmer leaving was a great loss lets hope its not a red flag.

[davethechef] 08/12/2020 21:36

From today's Equity Development's 'take' on Kromek's news release
And today Kromek said that it had signed two D3S contract extensions (worth £460k in FY21) to provide networked ‘counter nuclear terrorism’ solutions for a European government-related firm. Bringing the total awarded with this client to >£2.5m over the past 2 years. Meaning these new follow-on orders certainly are not ‘early-stage’. Instead, we think Kromek is inching closer to securing several large scale deployments of its leading D3S technology across major international conurbations. Each of which have the potential to generate £ms in revenues.

Better still, after being rocked during the height of the pandemic, it appears the Group’s 3 core markets – namely Medical Imaging (elective procedures), Homeland Security (lockdowns) & Airport Screening (passenger flights) – are all now recovering at various speeds. Boding well for the rest of FY21 & beyond; and in terms of valuation the stock at 12p trades on just a 2.9x trailing EV/sales multiple vs >5x for similarly ‘disruptive217; IPR-rich tech peers.
[...]

[sev22] 08/12/2020 15:04

Kromek - Detect/Image/identify

REGISTER TODAY

D-Martix Webinar
9th Dec 2020 - 1pm GMT

The D-Matrix gamma ray imager is a fully integrated, photon-counting, pixilated, 12-bit energy discriminating CZT detector/imager. The modular design enables a large field of view scaling.

In the webinar you will see:
Overview of the D-Matrix
Key features and applications
Q&A session
D-Matrix

Hosted by Madhuri Kaul – Applications & Product Manager, Medical.

Sign up to the launch webinar on 9th December 2020 at 1pm (GMT) to see what it is all about!

REGISTER TODAY

We will be recording the webinar, so if the time is not suitable for you, please still register and we will send you the recording afterwards.

To learn more about Kromek and our products, go to our website www.kromek.com

[paleje] 08/12/2020 09:33

Full ED note speculates this level could even attract an opportunistic bid. By all means but someone else would be getting the best out of all the hard work so far.

[davethechef] 08/12/2020 08:58

Yep, very encouraging news; recovery set & further contract extensions & new customers taking on Kromek's technology will accelarate.
hatfullofsky good timing!!!

[edmonda] 08/12/2020 07:54

Yes, good news as it signs 2 D3S contract extensions to provide networked ‘counter nuclear terrorism’ solutions in Europe; and CEO says evidence of 'rebound in commercial activity'

Stock still lowly rated, as per new research note from Equity Development:

[brummy_git] 08/12/2020 07:41

All the latest news & analysis, wrt KMK's D3S contract wins & positive trading update today - can be found here:

hxxps://www.linkedin.com/posts/paul-hill-a5994116_kmk-covid-activity-6741973600397508608-12CS

[hatfullofsky] 07/12/2020 13:51

Joined the party today at 12.05. Prepared to take a little pain but expect this to rise in Q1.

[davethechef] 03/12/2020 21:43

Still very much under the radar.
They're picking up the pace, re being proactive on showcasing their technology/products, I feel; further RNS's to match.
The fact that the chief medical officers keep 'drumming' into us( re Van Tam) that the dreaded virus isn't disappearing with us for years(if ever!) one would expect their products will be increasingly in demand, to detect, in all scenarios.

[value hound] 03/12/2020 08:48

I wouldn't be surprised to see these re-tipped by Simon Thompson of the IC on the back of today's news.

[edmonda] 03/12/2020 08:14

Evidence of the expanded product portfolio today as today they launched the D5 RIID - the world's smallest high-accuracy radioisotope identification device. 'A new benchmark' in that field says CEO.

This is the first device out of their new D5 product range.

See recent research and CEO interview here:

[davethechef] 01/12/2020 22:35

Indeed, nice find & recommendation there, sev22

[sev22] 01/12/2020 21:49

Another piece of positive news.

RMD’s CLLBC Technology Successfully Integrated in Kromek’s Award-Winning RIID.